查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
雙特異性抗體治療合約製造市場，按適應症、給藥途徑、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1419079

雙特異性抗體治療合約製造市場，按適應症、給藥途徑、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Bispecific Antibody Therapeutics Contract Manufacturing Market, By Indication, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年雙特異性抗體治療合約製造市場規模為52.891億美元，2023年至2030年CAGR為36.23%。

雙特異性抗體治療合約製造市場-市場動態

越來越重視新療法的開發和研發投資以推動市場需求

在預測期內，雙特異性抗體（bsAB）療法的合約製造市場預計將成長，這主要是由於旨在尋找新療法的研發工作的增加。在過去幾年中，市場呈指數級擴張，預計這種趨勢將在分析期間持續下去。造成這種情況的主要原因是在整個預測期間可能會引入雙特異性抗體的強大管道。此外，市場獲利擴張的關鍵促進因素是抗癌治療產品線的不斷擴大。例如，根據美國 FDA 的數據，截至 2022 年，臨床試驗中超過 85% 的雙特異性抗體旨在治療癌症。

此外，由於雙特異性抗體療法在治療癌症和其他疾病方面具有如此巨大的治療潛力，因此自大流行以來，對它們的需求一直在增加。此外，幾種雙特異性抗體目前正處於臨床開發的早期階段。因此，在未來幾年，預計這方面將對市場成長產生正面影響。此外，雙特異性抗體療法正在開發中，預計將增加市場擴張機會。

雙特異性抗體治療合約製造市場 - 關鍵見解

  • 根據我們的研究分析師分享的分析，預計全球市場在預測期內（2023-2030 年）每年將以 36.23% 左右的CAGR成長
  • 根據適應症細分，由於對癌症免疫治療的高需求，預計癌症細分市場將在 2022 年顯示最大的市場佔有率。
  • 根據給藥途徑細分，靜脈注射部分是 2022 年的領先部分，主要是由於其在癌症和免疫系統建構方面的有效性。
  • 根據最終用戶細分，生物製藥公司細分市場是 2022 年的領先細分市場，這主要是由於臨床試驗需求的增加。
  • 從地區來看，由於高研發和新藥發現，北美是 2022 年的主要收入來源。

雙特異性抗體治療合約製造市場-細分分析：

全球雙特異性抗體治療合約製造市場根據適應症、給藥途徑、最終用戶和地區進行細分。

根據適應症，市場分為五類：癌症、傳染病、自體發炎和自體免疫疾病、中樞神經系統疾病等。癌症領域佔市場主導地位。癌症有效療法的快速發展正在推動細分市場的成長。

根據給藥途徑，市場分為三類：靜脈注射、皮下注射和其他。靜脈注射細分市場在市場上佔據主導地位，並可能在預測期內保持其主導地位。皮下給藥途徑的日益採用可能會促進市場成長。

根據最終用戶，市場分為三類：生物製藥公司、研究機構和其他。生物製藥公司細分市場佔據主導地位，並可能在預測期內保持其主導地位。對新藥和改進藥物的需求增加正在推動治療需求。

雙特異性抗體治療合約製造市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

雙特異性抗體治療合約製造市場-競爭格局：

雙特異性抗體治療合約製造市場本質上競爭適度。市場上的主要參與者都致力於採用無機策略舉措，例如併購、合作夥伴關係和研發活動。例如，歐盟委員會於2022年6月授權有條件上市CD20xCD3 T細胞結合藥物bsAB Lunsumio（mosunetuzumab），將適用於復發或抗藥性濾泡性淋巴瘤患者。

最近的發展：

2023 年 3 月，InvoX Pharma Limited 報告稱，InvoX 子公司 F-star 已同意與武田合作開發免疫腫瘤學 bsAB。

目錄

第 1 章：雙特異性抗體治療合約製造市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 雙特異性抗體治療合約製造市場片段（按適應症）
    • 按給藥途徑分類的雙特異性抗體治療合約製造市場片段
    • 最終用戶的雙特異性抗體治療合約製造市場片段
    • 按國家/地區分類的雙特異性抗體治療合約製造市場片段
    • 按地區分類的雙特異性抗體治療合約製造市場片段
  • 競爭洞察

第 3 章：雙特異性抗體治療合約製造主要市場趨勢

  • 雙特異性抗體治療合約製造市場促進因素
    • 市場促進因素的影響分析
  • 雙特異性抗體治療合約製造市場限制
    • 市場限制影響分析
  • 雙特異性抗體治療合約製造市場機會
  • 雙特異性抗體治療合約製造市場未來趨勢

第 4 章：雙特異性抗體治療合約製造業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：雙特異性抗體治療合約製造市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：雙特異性抗體治療合約製造市場格局

  • 2022 年雙特異性抗體治療合約製造市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：雙特異性抗體治療合約製造市場 - 按適應症

  • 概述
    • 按指標分類的細分市場佔有率分析
    • 癌症
    • 傳染性疾病
    • 自體發炎與自體免疫疾病
    • 中樞神經系統疾病
    • 其他

第 8 章：雙特異性抗體治療合約製造市場 - 按給藥途徑

  • 概述
    • 按給藥途徑分類的細分市佔率分析
    • 靜脈
    • 皮下
    • 其他

第 9 章：雙特異性抗體治療合約製造市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 生物製藥公司
    • 研究機構
    • 其他

第 10 章：雙特異性抗體治療合約製造市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 雙特異性抗體療法合約製造北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按指標）
    • 北美市場規模與預測（按管理途徑）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 雙特異性抗體療法合約製造歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按指標）
    • 歐洲市場規模與預測（按管理途徑）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 雙特異性抗體療法合約製造亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依指標）
    • 亞太地區市場規模與預測（依管理途徑）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 雙特異性抗體療法合約製造拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按指標）
    • 拉丁美洲市場規模與預測（按管理途徑）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 雙特異性抗體療法合約製造中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（依指標）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 雙特異性抗體治療合約製造業

  • 競爭儀表板
  • 公司簡介
    • Lonza Group
    • Roche's
    • Thermo Fisher Scientific
    • Creative Biolabs
    • AbbVie
    • Amgen
    • Janssen
    • Johnson & Johnson
    • IQVIA
    • WuXi Biologics
    • Context Therapeutics
    • Sino Biological Inc.
    • KBI Biopharma
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2144

REPORT HIGHLIGHT

Bispecific Antibody Therapeutics Contract Manufacturing Market size was valued at USD 5,289.1 Million in 2022, expanding at a CAGR of 36.23% from 2023 to 2030.

Therapeutics using bispecific antibodies Contract manufacturing is the practice of contracting out to specialist contract manufacturing organizations (CMOs) the manufacturing procedures involved in creating bispecific antibodies. Bispecific antibodies are a class of medicinal compounds designed to target two different antigens at the same time. These antigens are frequently found on the surface of cells that are linked to diseases such as infectious diseases, autoimmune disorders, and cancer.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Market Dynamics

Increasing emphasis on novel therapeutics development and R&D investment to propel market demand

During the forecast period, the market for contract manufacturing of bispecific antibody (bsAB) therapies is expected to grow primarily due to increased research and development efforts aimed at finding new therapeutics. The market has been seeing exponential expansion over the last few years, and this trend is expected to continue over the analysis period. The main reason for this is the strong pipeline of bispecific antibodies that will probably be introduced throughout the projection period. Moreover, a key driver of the market's profitable expansion is the expanding pipeline of anti-cancer treatments. For example, according to the U.S. FDA, more than 85% of bispecific antibodies in clinical trials are intended to treat cancer as of 2022.

Furthermore, as bispecific antibody therapies have such significant therapeutic potential in treating cancer and other disorders, there has been an increase in demand for them since the pandemic. Moreover, several bispecific antibodies are now in the early stages of clinical development. Therefore, in the upcoming years, it is anticipated that this aspect will positively affect market growth. Furthermore, there is a developing pipeline of bispecific antibody therapies, which is anticipated to boost market expansion opportunities.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 36.23% over the forecast period (2023-2030)
  • Based on Indication segmentation, cancer segment was predicted to show maximum market share in the year 2022, owing to high need for cancer immunotherapy.
  • Based on Route of Administration segmentation, intravenous segment was the leading segment in 2022, mainly due to its effectiveness in cancer and immune system building.
  • Based on End-User segmentation, biopharmaceutical companies' segment was the leading segment in 2022, mainly due to increasing demand from clinical trials.
  • On the basis of region, North America was the leading revenue generator in 2022, owing to high R&D and novel drugs discovery.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Segmentation Analysis:

The Global Bispecific Antibody Therapeutics Contract Manufacturing Market is segmented on the basis of Indication, Route of Administration, End-User, and Region.

The market is divided into five categories based on Indication: cancer, infectious diseases, autoinflammatory and autoimmune diseases, CNS Conditions, and others. The cancer segment dominates the market. Rapid developments in cancer effective therapies are boosting segment growth.

The market is divided into three categories based on Route of Administration: intravenous, subcutaneous, and others. The intravenous segment dominates the market and is likely to maintain its dominance during the forecast period. The growing adoption of the subcutaneous route of administration is likely to boost market growth.

The market is divided into three categories based on End-User: biopharmaceutical companies, research institutes, and others. The biopharmaceutical companies segment dominates the market and is likely to maintain its dominance during the forecast period. Increased need for new and improved drugs is boosting the therapeutics demand.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Competitive Landscape:

Bispecific antibody therapeutics contract manufacturing market is moderately competitive in nature. The major players in the market are engaged on the adoption of in-organic strategic initiatives, such as mergers & acquisitions, partnerships, and R&D activities. For example, the European Commission authorized the conditional marketing of bsAB Lunsumio (mosunetuzumab), a CD20xCD3 T-cell binding drug, in June 2022. It will be applied to patients with relapsed or resistant follicular lymphoma.

Recent Developments:

In March 2023, InvoX Pharma Limited reported that F-star, a subsidiary of InvoX, has agreed to collaborate with Takeda on an immuno-oncology bsAB.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET KEY PLAYERS

  • Lonza Group
  • Roche's
  • Thermo Fisher Scientific
  • Creative Biolabs
  • AbbVie
  • Amgen
  • Janssen
  • Johnson & Johnson
  • IQVIA
  • WuXi Biologics
  • Context Therapeutics
  • Sino Biological Inc.
  • KBI Biopharma
  • Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY INDICATION

  • Cancer
  • Infectious diseases
  • Autoinflammatory and autoimmune diseases
  • CNS Conditions
  • Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY ROUTE OF ADMINISTRATION

  • Intravenous
  • Subcutaneous
  • Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY END-USER

  • Biopharmaceutical companies
  • Research institutes
  • Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bispecific Antibody Therapeutics Contract Manufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Indication
    • 2.1.2. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Route of Administration
    • 2.1.3. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by End-User
    • 2.1.4. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Country
    • 2.1.5. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Region
  • 2.2. Competitive Insights

3. Bispecific Antibody Therapeutics Contract Manufacturing Key Market Trends

  • 3.1. Bispecific Antibody Therapeutics Contract Manufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bispecific Antibody Therapeutics Contract Manufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bispecific Antibody Therapeutics Contract Manufacturing Market Opportunities
  • 3.4. Bispecific Antibody Therapeutics Contract Manufacturing Market Future Trends

4. Bispecific Antibody Therapeutics Contract Manufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bispecific Antibody Therapeutics Contract Manufacturing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Bispecific Antibody Therapeutics Contract Manufacturing Market Landscape

  • 6.1. Bispecific Antibody Therapeutics Contract Manufacturing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bispecific Antibody Therapeutics Contract Manufacturing Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 7.1.2. Cancer
    • 7.1.3. Infectious diseases
    • 7.1.4. Autoinflammatory and autoimmune diseases
    • 7.1.5. CNS Conditions
    • 7.1.6. Others

8. Bispecific Antibody Therapeutics Contract Manufacturing Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Intravenous
    • 8.1.3. Subcutaneous
    • 8.1.4. Others

9. Bispecific Antibody Therapeutics Contract Manufacturing Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Biopharmaceutical companies
    • 9.1.3. Research institutes
    • 9.1.4. Others

10. Bispecific Antibody Therapeutics Contract Manufacturing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Bispecific Antibody Therapeutics Contract Manufacturing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Lonza Group
    • 11.2.2. Roche's
    • 11.2.3. Thermo Fisher Scientific
    • 11.2.4. Creative Biolabs
    • 11.2.5. AbbVie
    • 11.2.6. Amgen
    • 11.2.7. Janssen
    • 11.2.8. Johnson & Johnson
    • 11.2.9. IQVIA
    • 11.2.10. WuXi Biologics
    • 11.2.11. Context Therapeutics
    • 11.2.12. Sino Biological Inc.
    • 11.2.13. KBI Biopharma
    • 11.2.14. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Bispecific Antibody Therapeutics Contract Manufacturing Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication 2018-2030 (USD Million)
  • TABLE Bispecific Antibody Therapeutics Contract Manufacturing Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Bispecific Antibody Therapeutics Contract Manufacturing Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User 2018-2030 (USD Million)
  • TABLE Bispecific Antibody Therapeutics Contract Manufacturing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Bispecific Antibody Therapeutics Contract Manufacturing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Bispecific Antibody Therapeutics Contract Manufacturing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Indication segment market share analysis, 2022 & 2030
  • FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022 & 2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Bispecific Antibody Therapeutics Contract Manufacturing Market share and leading players, 2022
  • FIGURE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market share and leading players, 2022
  • FIGURE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market share and leading players, 2022
  • FIGURE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market share and leading players, 2022
  • FIGURE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market share analysis by country, 2022
  • FIGURE Germany Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market share analysis by country, 2022
  • FIGURE India Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market share analysis by country, 2022
  • FIGURE Brazil Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market share analysis by country, 2022
  • FIGURE Saudi Arabia Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)